ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

New Treatment Approach To Treating Brain Tumor

April 26, 2002

House panel examines use of grant funds.

September 23, 2005